Company intelligence / Profile preview

Curadel Pharma

Natick, Massachusetts, United Statescuradelpharma.com ↗
Ownership
Private
Employees
~25
Development stage
Phase 3
01

Overview

ZW800–1, a first-in-class zwitterionic drug for optical surgical navigation, has entered Phase 3 pivotal trials to highlight the ureter during abdominopelvic surgery. CPI–003 targeted alpha therapy program in preclinical/early development aims to prevent tumor resistance and regrowth in rare/metastatic cancers. The company’s platform demonstrates strong proof-of-concept data in both imaging and therapeutic applications.

Therapeutic areas
OncologyOther
Modalities
Targeted alpha therapies (TATs)Zwitterionic radiopharmaceuticalsImaging agents for surgical navigation
Industry
Biotech
02

Drug pipeline

4 assets

nizaracianine triflutate

3

3 more assets in the full pipeline.

Request access →
03

Partnerships

Tier 1 medical device company leading pivotal trial of ZW800‑11National Cancer Institute as an investor

Beyond the preview

Go deeper on Curadel Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Curadel Pharma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call